BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 7564726)

  • 1. A prospective study of antineutrophil cytoplasmic antibody (c-ANCA) and clinical criteria in diagnosing Wegener's granulomatosis.
    Rao JK; Allen NB; Feussner JR; Weinberger M
    Lancet; 1995 Oct; 346(8980):926-31. PubMed ID: 7564726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antineutrophil cytoplasmic antibodies in Wegener's granulomatosis and other diseases: clinical issues.
    Galperin C; Hoffman GS
    Cleve Clin J Med; 1994; 61(6):416-27. PubMed ID: 7828332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of testing for antineutrophil cytoplasm antibodies (ANCA) with a standard indirect immunofluorescence ANCA test in patients with upper or lower respiratory tract symptoms.
    Davenport A; Lock RJ; Wallington TB
    Thorax; 1994 Mar; 49(3):213-7. PubMed ID: 8202876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of anti-neutrophil cytoplasmic antibodies in scleritis associated with Wegener's granulomatosis.
    Soukiasian SH; Foster CS; Niles JL; Raizman MB
    Ophthalmology; 1992 Jan; 99(1):125-32. PubMed ID: 1741124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early diagnosis of otologic Wegener's granulomatosis using the serologic marker C-ANCA.
    Macias JD; Wackym PA; McCabe BF
    Ann Otol Rhinol Laryngol; 1993 May; 102(5):337-41. PubMed ID: 8489162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of anti-neutrophil cytoplasmic antibody (ANCA) for the diagnosis of Wegener's granulomatosis in the early stage].
    Maguchi S; Takizawa M; Ryu T; Oridate N; Fukuda S; Inuyama Y
    Nihon Jibiinkoka Gakkai Kaiho; 1993 Aug; 96(8):1288-96. PubMed ID: 8377061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wegener's granulomatosis.
    Harman LE; Margo CE
    Surv Ophthalmol; 1998; 42(5):458-80. PubMed ID: 9548575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineutrophil cytoplasmic antibodies in Wegener's granulomatosis.
    Wong SN; Shah V; Dillon MJ
    Arch Dis Child; 1998 Sep; 79(3):246-50. PubMed ID: 9875021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Foudroyant course of a therapy resistent Wegener's granulomatosis with negative c-ANCA].
    Ettl T; Pistner H; Schwarz S; Reichert TE; Driemel O
    Mund Kiefer Gesichtschir; 2007 Apr; 11(2):73-80. PubMed ID: 17406921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
    Csernok E; Ahlquist D; Ullrich S; Gross WL
    Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic utility of c-ANCA in Wegener's granulomatosis.
    Langford CA
    Cleve Clin J Med; 1998 Mar; 65(3):135-40. PubMed ID: 9540246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antineutrophil cytoplasmic autoantibodies in systemic vasculitis].
    Hagemo JS; Aasarød K; Moen T
    Tidsskr Nor Laegeforen; 2002 May; 122(12):1185-8. PubMed ID: 12089844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns.
    Wong RC; Silvestrini RA; Savige JA; Fulcher DA; Benson EM
    J Clin Pathol; 1999 Feb; 52(2):124-8. PubMed ID: 10396240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antineutrophil cytoplasmic antibody associated with pulmonary hemorrhage: Wegener's granulomatosis?
    Estrada CA; Zachariah JK; Kaul R; Scher EJ
    South Med J; 1992 Feb; 85(2):181-3. PubMed ID: 1738885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets.
    Miloslavsky EM; Lu N; Unizony S; Choi HK; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Fervenza F; Monach PA; Specks U; Stone JH
    Arthritis Rheumatol; 2016 Dec; 68(12):2945-2952. PubMed ID: 27428559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody.
    Westman KW; Selga D; Bygren P; Segelmark M; Baslund B; Wiik A; Wieslander J
    Kidney Int; 1998 May; 53(5):1230-6. PubMed ID: 9573537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunistic infection and antineutrophil cytoplasm antibodies in Wegener's granulomatosis.
    Carder PJ; Harrison DJ
    Respir Med; 1989 Sep; 83(5):421-4. PubMed ID: 2616825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative ANCA in Wegener's granulomatosis.
    Carrie S; Hughes KB; Watson MG
    J Laryngol Otol; 1994 May; 108(5):420-2. PubMed ID: 8035124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-ANCA as a marker of Wegener's disease.
    Franssen CF; Tervaert JW; Stegeman CA; Kallenberg CG
    Lancet; 1996 Jan; 347(8994):116; author reply 118. PubMed ID: 8538307
    [No Abstract]   [Full Text] [Related]  

  • 20. Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis.
    Boomsma MM; Damoiseaux JG; Stegeman CA; Kallenberg CG; Patnaik M; Peter JB; Tervaert JW
    J Immunol Methods; 2003 Mar; 274(1-2):27-35. PubMed ID: 12609530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.